CME Group Inc. diskutieren

Sell with target price 170.0

Buy CME Group Inc.

Sell CME Group Inc.

CME Group Inc. (NASDAQ: CME) had its "sell" rating re-affirmed by analysts at Rosenblatt Securities. They now have a $161.00 price target on the stock.

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Oppenheimer Holdings Inc. from $213.00 to $221.00. They now have an "outperform" rating on the stock.

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Citigroup Inc. from $210.00 to $215.00. They now have a "buy" rating on the stock.

CME Group Inc. (NASDAQ: CME) had its "sell" rating re-affirmed by analysts at Rosenblatt Securities. They now have a $173.00 price target on the stock.

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $224.00 to $240.00. They now have a "buy" rating on the stock.

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Citigroup Inc. from $215.00 to $240.00. They now have a "buy" rating on the stock.

CME Group Inc. (NASDAQ: CME) had its price target lowered by analysts at Barclays PLC from $247.00 to $244.00. They now have an "overweight" rating on the stock.

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Rosenblatt Securities from $173.00 to $180.00. They now have a "sell" rating on the stock.

CME Group Inc. (NASDAQ: CME) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $195.00 price target on the stock.

CME Group Inc. (NASDAQ: CME) had its "sell" rating re-affirmed by analysts at Rosenblatt Securities. They now have a $180.00 price target on the stock.

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at Argus from $225.00 to $245.00. They now have a "buy" rating on the stock.

CME Group Inc. (NASDAQ: CME) had its "sell" rating re-affirmed by analysts at Rosenblatt Securities. They now have a $187.00 price target on the stock, up previously from $185.00.

CME Group Inc. (NASDAQ: CME) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $187.00 price target on the stock, down previously from $206.00.

CME Group Inc. (NASDAQ: CME) had its price target lowered by analysts at Piper Sandler from $250.00 to $235.00. They now have an "overweight" rating on the stock.

CME Group Inc. (NASDAQ: CME) had its price target lowered by analysts at Piper Sandler from $235.00 to $225.00. They now have an "overweight" rating on the stock.

CME Group Inc. (NASDAQ: CME) had its price target raised by analysts at JPMorgan Chase & Co. from $187.00 to $191.00. They now have an "underweight" rating on the stock.

Hey there! CME Group's looking pretty solid right now. They just declared a juicy $1.15 quarterly dividend, which is always a good sign. But what's really got me excited is their record-breaking July performance. We're talking a whopping 24.8 million contracts in average daily volume - that's up 24% from last year! It's like they've hit the jackpot in every asset class. Their interest rate products are on fire, with nearly 12 million contracts daily. And don't even get me started on their lithium futures - they're breaking records left and right. It's like CME's caught lightning in a bottle with the booming demand for battery metals. Sure, there are some headwinds in the agricultural sector, with farmers worried about input costs and crop prices. But overall, CME seems to be playing their cards right in this volatile market. With their diverse product range and strong performance, I think they've got room to grow. Just remember, the market's as unpredictable as a game of poker, so always do your own homework!